findmyKOL
Clinical trialNCT02802267UnknownPhase 2Interventional

Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy

SponsorHybrigenics CorporationEnrollment110Acute Myelogenous Leukemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Necker Hospital- Aphp

    Paris, France

    Recruiting
United States
  • Scripps Health

    San Diego, California, United States

    Recruiting
  • Georgia Cancer Center-Augusta University

    Augusta, Georgia, United States

    Recruiting
  • Comprehensive Cancer Centers of Nevada

    Las Vegas, Nevada, United States

    Edwin Kingsley, MD
    Recruiting
  • New Mexico Cancer Care Alliance

    Albuquerque, New Mexico, United States

    Cecilia Arana-Yi, MD
    Recruiting
  • Duke Cancer Institute, Duke Univ Medical Center

    Durham, North Carolina, United States

    Recruiting
  • University of Texas; M D Anderson Cancer Center

    Houston, Texas, United States

    Recruiting
  • Prohealth Care Inc

    Waukesha, Wisconsin, United States

    Timothy Wassenaar, MD
    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2016
Primary completion
31 Dec 2018
Completion
31 Dec 2019
Last update posted
2 Jul 2017
Registered enrollment
110
Registry id
NCT02802267
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.